Least Square Means (LSM) plots for factors impacting infected area on plates. by Alla Bezhentseva (12481585)

Subjects:

Theoretical model diagram. by Qi Zhang (28502)

Subjects:

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Thermoneutrality decreased sepsis survival. by Goldia Chan (21453340)

Kaplan-Meier curves for time until depression/anxiety stratified by OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Overview of study design and timeline. by G. Craig Wood (7522025)

Subjects:

Kaplan-Meier curves for time until cancer stratified by sex and OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Poisson Regression for days with healthcare utilization visits per year compared within Weight Loss Maintainers. by G. Craig Wood (7522025)

Subjects:

Baseline descriptive statistics of the study population. by G. Craig Wood (7522025)

Subjects:

Adjusted Cox regression model for time until health-related outcomes. by G. Craig Wood (7522025)

Subjects:

Kaplan-Meier curves for time until osteoarthritis within the WLM group stratified by the amount of weight loss at the end of the 2+ year index period. by G. Craig Wood (7522025)

Subjects:

Poisson regression for days with healthcare utilization visits per year compared between study groups. by G. Craig Wood (7522025)

Subjects:

The results of GO functional enrichment analysis (Annotation: The higher the value, the greater the importance). by Lin Zhou (141050)

Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization. by Kun Cui (2070772)

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”

Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Patient, operative and hospital characteristics stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Unadjusted in-hospital clinical and financial outcomes stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Adjusted in-hospital clinical outcomes associated with left atrial appendage occlusion utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Temporal trends in the proportion of left atrial appendage occlusion (LAAO) cases stratified by sex. by Ayesha P. Ng (15909876)

Subjects: